Key result
Intra-arterial neoadjuvant chemotherapy for oropharyngeal carcinoma provides only temporary tumor volume reduction and has not been shown to significantly increase overall survival.
Regional intra-arterial neoadjuvant chemotherapy for oropharyngeal carcinoma yields only temporary remission without significantly extending life expectancy, highlighting the potential need for pre-treatment molecular profiling to guide targeted therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Šimek et al. (2007) conducted a review in Oropharyngeal carcinoma. Intra-arterial neoadjuvant chemotherapy was evaluated. Intra-arterial neoadjuvant chemotherapy for oropharyngeal carcinoma provides only temporary tumor volume reduction and has not been shown to significantly increase overall survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: